annual CAPEX:
$97.42M-$10.19M(-9.47%)Summary
- As of today (July 1, 2025), BMRN annual capital expenditures is $97.42 million, with the most recent change of -$10.19 million (-9.47%) on December 31, 2024.
- During the last 3 years, BMRN annual CAPEX has fallen by -$21.81 million (-18.29%).
- BMRN annual CAPEX is now -57.21% below its all-time high of $227.65 million, reached on December 31, 2015.
Performance
BMRN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$16.77M-$3.53M(-17.39%)Summary
- As of today (July 1, 2025), BMRN quarterly capital expenditures is $16.77 million, with the most recent change of -$3.53 million (-17.39%) on March 31, 2025.
- Over the past year, BMRN quarterly CAPEX has dropped by -$17.34 million (-50.83%).
- BMRN quarterly CAPEX is now -83.85% below its all-time high of $103.81 million, reached on December 31, 2015.
Performance
BMRN quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$80.08M-$17.34M(-17.80%)Summary
- As of today (July 1, 2025), BMRN TTM capital expenditures is $80.08 million, with the most recent change of -$17.34 million (-17.80%) on March 31, 2025.
- Over the past year, BMRN TTM CAPEX has dropped by -$36.87 million (-31.52%).
- BMRN TTM CAPEX is now -65.03% below its all-time high of $229.03 million, reached on March 31, 2016.
Performance
BMRN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BMRN CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -9.5% | -50.8% | -31.5% |
3 y3 years | -18.3% | -45.3% | -34.2% |
5 y5 years | -40.4% | -61.9% | -53.9% |
BMRN CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -25.9% | at low | -54.3% | at low | -42.6% | at low |
5 y | 5-year | -40.4% | at low | -62.2% | at low | -53.9% | at low |
alltime | all time | -57.2% | +2490.9% | -83.8% | +3453.6% | -65.0% | >+9999.0% |
BMRN CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $16.77M(-17.4%) | $80.08M(-17.8%) |
Dec 2024 | $97.42M(-9.5%) | $20.30M(-4.1%) | $97.42M(-14.4%) |
Sep 2024 | - | $21.18M(-3.0%) | $113.81M(-1.9%) |
Jun 2024 | - | $21.84M(-36.0%) | $116.06M(-0.8%) |
Mar 2024 | - | $34.10M(-7.1%) | $116.95M(+8.7%) |
Dec 2023 | $107.61M(-18.2%) | $36.70M(+56.7%) | $107.61M(+0.3%) |
Sep 2023 | - | $23.42M(+3.0%) | $107.27M(-10.8%) |
Jun 2023 | - | $22.73M(-8.2%) | $120.33M(-4.2%) |
Mar 2023 | - | $24.77M(-31.9%) | $125.63M(-4.5%) |
Dec 2022 | $131.54M(+10.3%) | $36.36M(-0.3%) | $131.54M(-5.7%) |
Sep 2022 | - | $36.47M(+30.1%) | $139.54M(+13.1%) |
Jun 2022 | - | $28.04M(-8.6%) | $123.43M(+1.5%) |
Mar 2022 | - | $30.68M(-30.8%) | $121.65M(+2.0%) |
Dec 2021 | $119.22M(-13.3%) | $44.36M(+117.9%) | $119.22M(+3.9%) |
Sep 2021 | - | $20.36M(-22.4%) | $114.73M(+0.2%) |
Jun 2021 | - | $26.25M(-7.1%) | $114.52M(-5.9%) |
Mar 2021 | - | $28.25M(-29.1%) | $121.76M(-11.5%) |
Dec 2020 | $137.52M(-15.8%) | $39.86M(+97.8%) | $137.52M(-13.2%) |
Sep 2020 | - | $20.15M(-39.8%) | $158.50M(-8.8%) |
Jun 2020 | - | $33.48M(-23.9%) | $173.75M(-1.8%) |
Mar 2020 | - | $44.02M(-27.7%) | $176.96M(+8.3%) |
Dec 2019 | $163.41M(+13.0%) | $60.84M(+71.8%) | $163.41M(+13.0%) |
Sep 2019 | - | $35.41M(-3.5%) | $144.64M(-9.1%) |
Jun 2019 | - | $36.70M(+20.5%) | $159.09M(+9.8%) |
Mar 2019 | - | $30.46M(-27.6%) | $144.92M(+0.2%) |
Dec 2018 | $144.62M(-27.4%) | $42.08M(-15.6%) | $144.62M(+1.5%) |
Sep 2018 | - | $49.86M(+121.4%) | $142.43M(+5.5%) |
Jun 2018 | - | $22.52M(-25.3%) | $135.05M(-15.7%) |
Mar 2018 | - | $30.16M(-24.4%) | $160.29M(-19.5%) |
Dec 2017 | $199.22M(+34.3%) | $39.89M(-6.1%) | $199.22M(-5.5%) |
Sep 2017 | - | $42.48M(-11.0%) | $210.90M(+8.4%) |
Jun 2017 | - | $47.76M(-30.9%) | $194.52M(+12.9%) |
Mar 2017 | - | $69.09M(+34.0%) | $172.27M(+16.1%) |
Dec 2016 | $148.38M(-34.8%) | $51.57M(+97.6%) | $148.38M(-26.0%) |
Sep 2016 | - | $26.10M(+2.3%) | $200.62M(-8.4%) |
Jun 2016 | - | $25.51M(-43.6%) | $219.07M(-4.3%) |
Mar 2016 | - | $45.20M(-56.5%) | $229.03M(+0.6%) |
Dec 2015 | $227.65M(+94.5%) | $103.81M(+133.0%) | $227.65M(+50.2%) |
Sep 2015 | - | $44.56M(+25.7%) | $151.61M(+14.7%) |
Jun 2015 | - | $35.46M(-19.1%) | $132.22M(-3.7%) |
Mar 2015 | - | $43.83M(+57.9%) | $137.29M(+17.3%) |
Dec 2014 | $117.06M(+79.6%) | $27.77M(+10.3%) | $117.06M(-1.7%) |
Sep 2014 | - | $25.17M(-37.9%) | $119.05M(+11.2%) |
Jun 2014 | - | $40.52M(+71.6%) | $107.08M(+39.1%) |
Mar 2014 | - | $23.61M(-20.7%) | $76.97M(+18.1%) |
Dec 2013 | $65.19M(+46.3%) | $29.75M(+125.4%) | $65.19M(+32.1%) |
Sep 2013 | - | $13.20M(+26.8%) | $49.34M(-3.5%) |
Jun 2013 | - | $10.41M(-12.0%) | $51.15M(+1.8%) |
Mar 2013 | - | $11.83M(-14.9%) | $50.22M(+12.7%) |
Dec 2012 | $44.57M(-71.1%) | $13.89M(-7.4%) | $44.57M(-63.0%) |
Sep 2012 | - | $15.01M(+58.3%) | $120.36M(-25.6%) |
Jun 2012 | - | $9.48M(+53.5%) | $161.73M(+4.9%) |
Mar 2012 | - | $6.18M(-93.1%) | $154.16M(-0.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $154.22M(+211.8%) | $89.68M(+59.0%) | $154.22M(+104.9%) |
Sep 2011 | - | $56.39M(+2852.3%) | $75.28M(+166.3%) |
Jun 2011 | - | $1.91M(-69.4%) | $28.26M(-32.0%) |
Mar 2011 | - | $6.24M(-41.9%) | $41.59M(-15.9%) |
Dec 2010 | $49.46M(-44.9%) | $10.74M(+14.6%) | $49.46M(-19.4%) |
Sep 2010 | - | $9.37M(-38.5%) | $61.34M(-21.9%) |
Jun 2010 | - | $15.24M(+8.0%) | $78.53M(-7.8%) |
Mar 2010 | - | $14.11M(-37.6%) | $85.17M(-5.2%) |
Dec 2009 | $89.80M(+59.3%) | $22.62M(-14.8%) | $89.80M(+13.5%) |
Sep 2009 | - | $26.56M(+21.4%) | $79.10M(+22.3%) |
Jun 2009 | - | $21.88M(+16.8%) | $64.66M(+17.1%) |
Mar 2009 | - | $18.74M(+57.2%) | $55.22M(-2.0%) |
Dec 2008 | $56.37M(+151.5%) | $11.92M(-1.6%) | $56.37M(+3.7%) |
Sep 2008 | - | $12.11M(-2.7%) | $54.38M(+13.5%) |
Jun 2008 | - | $12.44M(-37.4%) | $47.92M(+22.7%) |
Mar 2008 | - | $19.89M(+100.2%) | $39.07M(+74.3%) |
Dec 2007 | $22.41M(-8.8%) | $9.94M(+75.9%) | $22.41M(+42.8%) |
Sep 2007 | - | $5.65M(+57.2%) | $15.69M(+25.4%) |
Jun 2007 | - | $3.59M(+11.1%) | $12.51M(-53.6%) |
Mar 2007 | - | $3.23M(+0.6%) | $26.95M(+9.6%) |
Dec 2006 | $24.58M(+279.0%) | $3.22M(+30.3%) | $24.58M(-6.5%) |
Sep 2006 | - | $2.47M(-86.3%) | $26.30M(+8.0%) |
Jun 2006 | - | $18.03M(+1974.6%) | $24.35M(+259.5%) |
Mar 2006 | - | $869.00K(-82.4%) | $6.77M(+4.4%) |
Dec 2005 | $6.49M(-73.1%) | $4.94M(+864.6%) | $6.49M(-29.7%) |
Sep 2005 | - | $512.00K(+13.0%) | $9.22M(-52.6%) |
Jun 2005 | - | $453.00K(-22.2%) | $19.46M(-16.9%) |
Mar 2005 | - | $582.00K(-92.4%) | $23.43M(-2.7%) |
Dec 2004 | $24.07M(+302.9%) | $7.67M(-28.6%) | $24.07M(+22.0%) |
Sep 2004 | - | $10.75M(+143.1%) | $19.74M(+81.8%) |
Jun 2004 | - | $4.42M(+258.8%) | $10.86M(+54.3%) |
Mar 2004 | - | $1.23M(-63.1%) | $7.04M(+17.8%) |
Dec 2003 | $5.97M(+22.9%) | $3.34M(+79.0%) | $5.97M(+92.0%) |
Sep 2003 | - | $1.86M(+209.8%) | $3.11M(+316.6%) |
Jun 2003 | - | $602.00K(+254.1%) | $747.00K(-73.2%) |
Mar 2003 | - | $170.00K(-64.2%) | $2.79M(-42.7%) |
Dec 2002 | $4.86M(-72.7%) | $475.00K(-195.0%) | $4.86M(-57.0%) |
Sep 2002 | - | -$500.00K(-118.9%) | $11.30M(-37.6%) |
Jun 2002 | - | $2.64M(+17.6%) | $18.11M(-7.7%) |
Mar 2002 | - | $2.25M(-67.5%) | $19.63M(+10.2%) |
Dec 2001 | $17.81M(+373.7%) | $6.91M(+9.4%) | $17.81M(+40.3%) |
Sep 2001 | - | $6.32M(+51.9%) | $12.70M(+79.6%) |
Jun 2001 | - | $4.16M(+866.5%) | $7.07M(+97.4%) |
Mar 2001 | - | $430.00K(-76.1%) | $3.58M(-4.7%) |
Dec 2000 | $3.76M(-83.6%) | $1.80M(+161.7%) | $3.76M(-35.2%) |
Sep 2000 | - | $687.00K(+3.0%) | $5.81M(-53.2%) |
Jun 2000 | - | $667.00K(+9.7%) | $12.42M(-40.2%) |
Mar 2000 | - | $608.00K(-84.2%) | $20.77M(-9.5%) |
Dec 1999 | $22.94M(+258.5%) | $3.84M(-47.3%) | $22.94M(+20.1%) |
Sep 1999 | - | $7.30M(-19.1%) | $19.10M(+61.9%) |
Jun 1999 | - | $9.02M(+224.3%) | $11.80M(+324.3%) |
Mar 1999 | - | $2.78M | $2.78M |
Dec 1998 | $6.40M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual capital expenditures?
- What is the all time high annual CAPEX for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual CAPEX year-on-year change?
- What is BioMarin Pharmaceutical quarterly capital expenditures?
- What is the all time high quarterly CAPEX for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly CAPEX year-on-year change?
- What is BioMarin Pharmaceutical TTM capital expenditures?
- What is the all time high TTM CAPEX for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM CAPEX year-on-year change?
What is BioMarin Pharmaceutical annual capital expenditures?
The current annual CAPEX of BMRN is $97.42M
What is the all time high annual CAPEX for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual capital expenditures is $227.65M
What is BioMarin Pharmaceutical annual CAPEX year-on-year change?
Over the past year, BMRN annual capital expenditures has changed by -$10.19M (-9.47%)
What is BioMarin Pharmaceutical quarterly capital expenditures?
The current quarterly CAPEX of BMRN is $16.77M
What is the all time high quarterly CAPEX for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly capital expenditures is $103.81M
What is BioMarin Pharmaceutical quarterly CAPEX year-on-year change?
Over the past year, BMRN quarterly capital expenditures has changed by -$17.34M (-50.83%)
What is BioMarin Pharmaceutical TTM capital expenditures?
The current TTM CAPEX of BMRN is $80.08M
What is the all time high TTM CAPEX for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM capital expenditures is $229.03M
What is BioMarin Pharmaceutical TTM CAPEX year-on-year change?
Over the past year, BMRN TTM capital expenditures has changed by -$36.87M (-31.52%)